Viewing StudyNCT04666168



Ignite Creation Date: 2024-05-06 @ 3:32 PM
Last Modification Date: 2024-10-26 @ 1:51 PM
Study NCT ID: NCT04666168
Status: RECRUITING
Last Update Posted: 2020-12-14
First Post: 2020-11-11

Brief Title: A Multicenter Clinical Study on the Safety and Efficacy of CAR-T in the Treatment of Relapsed Refractory Non Hodgkins Lymphoma
Sponsor: Hebei Senlang Biotechnology Inc Ltd
Organization: Hebei Senlang Biotechnology Inc Ltd

Organization Data

Organization: Hebei Senlang Biotechnology Inc Ltd
Class: INDUSTRY
Study ID: 2020102
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Hebei Senlang Biotechnology Inc Ltd
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Hebei Medical University Fourth Hospital OTHER